Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Massetti

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMJ Open|October 9, 2017
Organised screening for cervical cancer in France: a cost-effectiveness assessmentStéphanie Barré, Marc Massetti, Henri Leleu, et al.
Journal of Market Access & Health Policy|April 29, 2016
A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environmentsMarc Massetti, Samuel Aballéa, Yann Videau, et al.
Pharmacoeconomics - Open|September 6, 2025
Estimating Health State Utilities for IDH-Mutant Diffuse GliomaEllen M Howard, Marc Massetti, Gin Nie Chua, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Facing the COVID-19 epidemic in NYC: a stochastic agent-based model of various intervention strategiesNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
Neuro-Oncology Practice|May 11, 2026
Evaluating work activity and societal burden in patients with grade 2 IDH-mutant gliomaSlávka Lukacova, Aida Muhic, Oskar Ström, et al.
Nature Medicine|July 16, 2020
A stochastic agent-based model of the SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
Nature Medicine|October 17, 2020
Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
The Patient|June 13, 2026
Patient Preferences and Treatment Decision Drivers in IDH-Mutant Grade 2 Glioma: An International Discrete Choice ExperimentAshley Parham Ghiaseddin, Kismet Hossain-Ibrahim, Antje Wick, et al.
Targeted Oncology|July 16, 2022
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer RegistryCamille Verry, Sébastien Vincendeau, Marc Massetti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMJ Open|October 9, 2017
Organised screening for cervical cancer in France: a cost-effectiveness assessmentStéphanie Barré, Marc Massetti, Henri Leleu, et al.
Journal of Market Access & Health Policy|April 29, 2016
A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environmentsMarc Massetti, Samuel Aballéa, Yann Videau, et al.
Pharmacoeconomics - Open|September 6, 2025
Estimating Health State Utilities for IDH-Mutant Diffuse GliomaEllen M Howard, Marc Massetti, Gin Nie Chua, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Facing the COVID-19 epidemic in NYC: a stochastic agent-based model of various intervention strategiesNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
Neuro-Oncology Practice|May 11, 2026
Evaluating work activity and societal burden in patients with grade 2 IDH-mutant gliomaSlávka Lukacova, Aida Muhic, Oskar Ström, et al.
Nature Medicine|July 16, 2020
A stochastic agent-based model of the SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
Nature Medicine|October 17, 2020
Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.
The Patient|June 13, 2026
Patient Preferences and Treatment Decision Drivers in IDH-Mutant Grade 2 Glioma: An International Discrete Choice ExperimentAshley Parham Ghiaseddin, Kismet Hossain-Ibrahim, Antje Wick, et al.
Targeted Oncology|July 16, 2022
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer RegistryCamille Verry, Sébastien Vincendeau, Marc Massetti, et al.
Pageof 2